Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$33.32 - $40.98 $1.33 Million - $1.64 Million
39,946 New
39,946 $1.42 Million
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $1.75 Million - $2.97 Million
37,550 Added 606.04%
43,746 $2.06 Million
Q2 2022

Aug 09, 2022

BUY
$63.06 - $84.75 $390,719 - $525,111
6,196 New
6,196 $444,000
Q4 2021

Feb 10, 2022

SELL
$86.01 - $102.89 $434,350 - $519,594
-5,050 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$84.7 - $96.31 $237,160 - $269,668
2,800 Added 124.44%
5,050 $442,000
Q2 2021

Aug 11, 2021

SELL
$76.44 - $89.57 $358,962 - $420,620
-4,696 Reduced 67.61%
2,250 $201,000
Q1 2021

May 14, 2021

BUY
$67.36 - $80.76 $122,527 - $146,902
1,819 Added 35.48%
6,946 $527,000
Q4 2020

Feb 09, 2021

BUY
$53.08 - $69.86 $272,141 - $358,172
5,127 New
5,127 $349,000
Q1 2020

Apr 29, 2020

SELL
$32.64 - $73.63 $205,632 - $463,869
-6,300 Closed
0 $0
Q4 2019

Jan 23, 2020

SELL
$48.0 - $59.55 $272,208 - $337,708
-5,671 Reduced 47.37%
6,300 $375,000
Q3 2019

Oct 16, 2019

BUY
$46.64 - $55.39 $258,338 - $306,805
5,539 Added 86.12%
11,971 $637,000
Q2 2019

Jul 10, 2019

SELL
$40.81 - $52.42 $76,273 - $97,972
-1,869 Reduced 22.52%
6,432 $329,000
Q1 2019

May 10, 2019

BUY
$36.91 - $55.7 $21,481 - $32,417
582 Added 7.54%
8,301 $430,000
Q4 2018

Feb 08, 2019

BUY
$36.49 - $51.72 $73,673 - $104,422
2,019 Added 35.42%
7,719 $336,000
Q3 2018

Nov 08, 2018

BUY
$46.5 - $53.55 $265,050 - $305,235
5,700 New
5,700 $294,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.